Endpoints for validation of tumor markers for recurrence risk: Recurrence-free interval (RFI), disease-free survival (DFS), overall survival (OS), and colon-cancer specific survival (CCSS) in CALGB 9581
   Google Scholar   
Citation:
Eur J Cancer vol 47 (Suppl 1) S172
Meeting Instance:
ECCO 2011
Year:
2011
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
pub
Note:
Methodological:
No
Biospecimen:
No
SDC:
No
Parents:
None
Children:
989  
Program:
OGC
Primary Committee:
GI
Sec. Committees:
   
Pharmas:
 
Grants:
 
Corr. Author:
 
Authors:
             
Networks:
 
Study
Alliance-9581
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
Keywords: